Consequently, to determine the role of non‐pathogenic variants of APP, PSEN1, and PSEN2 in AD, we comprehensively analyzed these non‐pathogenic variants between AD patients and controls in a large Chinese population via a targeted sequencing panel. Here, PSEN2 is linked to Alzheimer disease.